These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30864238)

  • 1. Posaconazole salvage therapy: The Posifi study.
    Fortun J; Gioia F; Cardozo C; Gudiol C; Diago E; José Castón J; Muñoz P; López J; Puerta-Alcalde P; Enzenhofer M; Ramos A; Frutos A; Machado M; Garcia-Vidal C; Parody R; Martín-Dávila P
    Mycoses; 2019 Jun; 62(6):526-533. PubMed ID: 30864238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posaconazole salvage treatment for invasive fungal infection.
    Kim JH; Williams K
    Mycopathologia; 2014 Oct; 178(3-4):259-65. PubMed ID: 25103141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posaconazole: an extended-spectrum triazole antifungal agent.
    Schiller DS; Fung HB
    Clin Ther; 2007 Sep; 29(9):1862-86. PubMed ID: 18035188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posaconazole salvage treatment in paediatric patients: a multicentre survey.
    Lehrnbecher T; Attarbaschi A; Duerken M; Garbino J; Gruhn B; Kontny U; Lüer S; Phillips R; Scholz J; Wagner HJ; Wiesel T; Groll AH
    Eur J Clin Microbiol Infect Dis; 2010 Aug; 29(8):1043-5. PubMed ID: 20495990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of posaconazole oral suspension or delayed-released tablet salvage treatment for invasive fungal infection.
    Kim JH; Benefield RJ; Ditolla K
    Mycoses; 2016 Nov; 59(11):726-733. PubMed ID: 27392814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posaconazole: Use in the Prophylaxis and Treatment of Fungal Infections.
    Clark NM; Grim SA; Lynch JP
    Semin Respir Crit Care Med; 2015 Oct; 36(5):767-85. PubMed ID: 26398542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posaconazole.
    Keating GM
    Drugs; 2005; 65(11):1553-67; discussion 1568-9. PubMed ID: 16033292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety, clinical effectiveness and trough plasma concentrations of intravenous posaconazole in patients with haematological malignancies and/or undergoing allogeneic haematopoietic stem cell transplantation: off-trial experience.
    Jeong W; Haywood P; Shanmuganathan N; Lindsay J; Urbancic K; Ananda-Rajah MR; Chen SC; Bajel A; Ritchie D; Grigg A; Seymour JF; Peleg AY; Kong DC; Slavin MA
    J Antimicrob Chemother; 2016 Dec; 71(12):3540-3547. PubMed ID: 27521358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posaconazole as salvage therapy in patients with invasive fungal infections after solid organ transplant.
    Alexander BD; Perfect JR; Daly JS; Restrepo A; Tobón AM; Patino H; Hardalo CJ; Graybill JR
    Transplantation; 2008 Sep; 86(6):791-6. PubMed ID: 18813103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerability of isavuconazole after posaconazole toxicity in leukaemia patients.
    DiPippo AJ; Rausch CR; Kontoyiannis DP
    Mycoses; 2019 Jan; 62(1):81-86. PubMed ID: 30230043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter, open-label study of posaconazole oral suspension in the treatment of invasive fungal infections in patients refractory to or intolerant of first-line therapy.
    Huang X; Wang F; Chen Y; Liu T; Wang J; Hu J; Jie J; Chen F; Wang S; Shen Z; Yu L; Yu K; Liang Y
    Future Microbiol; 2012 Feb; 7(2):201-9. PubMed ID: 22324990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posaconazole: an oral triazole with an extended spectrum of activity.
    Rachwalski EJ; Wieczorkiewicz JT; Scheetz MH
    Ann Pharmacother; 2008 Oct; 42(10):1429-38. PubMed ID: 18713852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posaconazole: a new broad-spectrum antifungal agent.
    Kwon DS; Mylonakis E
    Expert Opin Pharmacother; 2007 Jun; 8(8):1167-78. PubMed ID: 17516880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial.
    Walsh TJ; Raad I; Patterson TF; Chandrasekar P; Donowitz GR; Graybill R; Greene RE; Hachem R; Hadley S; Herbrecht R; Langston A; Louie A; Ribaud P; Segal BH; Stevens DA; van Burik JA; White CS; Corcoran G; Gogate J; Krishna G; Pedicone L; Hardalo C; Perfect JR
    Clin Infect Dis; 2007 Jan; 44(1):2-12. PubMed ID: 17143808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posaconazole: a potent, extended-spectrum triazole anti-fungal for the treatment of serious fungal infections.
    Herbrecht R
    Int J Clin Pract; 2004 Jun; 58(6):612-24. PubMed ID: 15311563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posaconazole treatment in Korea: single-center experience over 5 years.
    Lee HJ; Kwon JC; Kim SH; Choi SM; Lee DG; Park SH; Choi JH; Yoo JH; Cho BS; Lee S; Kim HJ; Min CK; Lee JW; Min WS
    Yonsei Med J; 2013 Sep; 54(5):1234-40. PubMed ID: 23918575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic drug monitoring of posaconazole in hematology adults under posaconazole prophylaxis: influence of food intake.
    Eiden C; Meniane JC; Peyrière H; Eymard-Duvernay S; Le Falher G; Ceballos P; Fegueux N; Cociglio M; Reynes J; Hillaire-Buys D
    Eur J Clin Microbiol Infect Dis; 2012 Feb; 31(2):161-7. PubMed ID: 21611869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superior Serum Concentrations with Posaconazole Delayed-Release Tablets Compared to Suspension Formulation in Hematological Malignancies.
    Cumpston A; Caddell R; Shillingburg A; Lu X; Wen S; Hamadani M; Craig M; Kanate AS
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4424-8. PubMed ID: 25987632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posaconazole as salvage therapy for zygomycosis.
    Greenberg RN; Mullane K; van Burik JA; Raad I; Abzug MJ; Anstead G; Herbrecht R; Langston A; Marr KA; Schiller G; Schuster M; Wingard JR; Gonzalez CE; Revankar SG; Corcoran G; Kryscio RJ; Hare R
    Antimicrob Agents Chemother; 2006 Jan; 50(1):126-33. PubMed ID: 16377677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy, safety and feasibility of antifungal prophylaxis with posaconazole tablet in paediatric patients after haematopoietic stem cell transplantation.
    Döring M; Cabanillas Stanchi KM; Queudeville M; Feucht J; Blaeschke F; Schlegel P; Feuchtinger T; Lang P; Müller I; Handgretinger R; Heinz WJ
    J Cancer Res Clin Oncol; 2017 Jul; 143(7):1281-1292. PubMed ID: 28258343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.